IRIS
BOSSI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.919
NA - Nord America 8.230
SA - Sud America 1.657
EU - Europa 1.280
Continente sconosciuto - Info sul continente non disponibili 500
AF - Africa 170
OC - Oceania 7
Totale 20.763
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.856
SG - Singapore 5.626
CN - Cina 1.465
BR - Brasile 1.338
VN - Vietnam 744
IT - Italia 621
HK - Hong Kong 325
CA - Canada 180
IN - India 158
GB - Regno Unito 129
AR - Argentina 121
DE - Germania 119
MX - Messico 115
BD - Bangladesh 104
FR - Francia 68
ZA - Sudafrica 59
TR - Turchia 57
ID - Indonesia 55
ES - Italia 54
EC - Ecuador 52
IQ - Iraq 46
PL - Polonia 42
JP - Giappone 40
RU - Federazione Russa 38
CO - Colombia 36
VE - Venezuela 35
UA - Ucraina 34
MY - Malesia 33
NL - Olanda 32
PK - Pakistan 30
UZ - Uzbekistan 29
MA - Marocco 28
CL - Cile 24
NP - Nepal 24
SE - Svezia 23
SA - Arabia Saudita 22
KE - Kenya 20
TN - Tunisia 19
JO - Giordania 18
PH - Filippine 18
PY - Paraguay 18
AE - Emirati Arabi Uniti 17
JM - Giamaica 17
FI - Finlandia 15
UY - Uruguay 14
CR - Costa Rica 13
EG - Egitto 13
IE - Irlanda 12
TH - Thailandia 12
AT - Austria 11
LT - Lituania 11
IR - Iran 10
BE - Belgio 9
HN - Honduras 9
KZ - Kazakistan 9
PE - Perù 9
TW - Taiwan 9
BA - Bosnia-Erzegovina 8
OM - Oman 8
CH - Svizzera 7
ET - Etiopia 7
IL - Israele 7
SV - El Salvador 7
AL - Albania 6
AM - Armenia 6
DZ - Algeria 6
NI - Nicaragua 6
RO - Romania 6
TT - Trinidad e Tobago 6
AU - Australia 5
BY - Bielorussia 5
CY - Cipro 5
GE - Georgia 5
HR - Croazia 5
KR - Corea 5
PR - Porto Rico 5
RS - Serbia 5
AZ - Azerbaigian 4
BH - Bahrain 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
HU - Ungheria 4
LB - Libano 4
PS - Palestinian Territory 4
SN - Senegal 4
BB - Barbados 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
GY - Guiana 3
PA - Panama 3
QA - Qatar 3
SR - Suriname 3
AO - Angola 2
BW - Botswana 2
GA - Gabon 2
GD - Grenada 2
KH - Cambogia 2
KW - Kuwait 2
LK - Sri Lanka 2
Totale 20.235
Salva come PNG Salva come JPEG
Città #
Singapore 2.292
San Jose 1.513
Ashburn 1.330
The Dalles 920
Dallas 549
Shanghai 538
Council Bluffs 527
Beijing 364
Hong Kong 301
Ho Chi Minh City 286
Santa Clara 282
Los Angeles 227
Milan 203
New York 185
Hanoi 162
Buffalo 147
São Paulo 110
Seattle 93
Rome 67
Assago 62
Orem 50
Chicago 49
Montreal 47
Mexico City 46
Atlanta 44
Johannesburg 42
Naples 38
Rio de Janeiro 38
Boardman 37
Charlotte 36
Phoenix 36
Warsaw 36
Curitiba 34
Munich 34
San Francisco 33
Toronto 33
Brooklyn 32
Tokyo 31
Da Nang 30
Haiphong 28
Tashkent 28
Campinas 26
London 26
Belo Horizonte 24
Chennai 24
Frankfurt am Main 24
Brasília 21
Denver 21
Houston 21
Stockholm 21
Boston 19
Guayaquil 19
Manchester 19
Mumbai 18
Nairobi 18
Ribeirão Preto 18
Secaucus 18
Kuala Lumpur 17
New Delhi 17
Amsterdam 16
Dhaka 16
Quito 16
Baghdad 15
Figino 15
Turin 15
Istanbul 14
Poplar 14
Santiago 14
Amman 13
Biên Hòa 13
Goiânia 13
Tunis 13
Wilmington 13
Bogotá 12
Bologna 12
Buenos Aires 12
Caracas 12
Chandler 12
Hải Dương 12
Paris 12
Pasadena 12
Porto Alegre 12
Ankara 11
Cleveland 11
Dublin 11
Fortaleza 11
Karachi 11
Las Vegas 11
Milwaukee 11
Montevideo 11
Philadelphia 11
Salvador 11
Hangzhou 10
Helsinki 10
Juneau 10
Kingston 10
Vancouver 10
Bengaluru 9
Genoa 9
Hillsboro 9
Totale 11.806
Salva come PNG Salva come JPEG
Nome #
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents 249
New trends in supportive care of head and neck cancers 123
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis 117
Ectopic olfactory neuroblastoma is associated with increased frequency of syndrome of inappropriate antidiuretic hormone secretion and reduced disease control: Case series with systematic review and pooled analysis 111
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer 104
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy 103
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer 101
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck 100
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact 93
A case of otoliquorrhoea secondary to immunotherapy response in head and neck cutaneous squamous cell carcinoma. When abrupt response may worry the physician 90
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6 89
Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents 89
Treatment decision-making factors and sequencing in recurrent and/or metastatic squamous cell carcinoma of the head and neck 88
Improving the multidisciplinary therapeutic management of head and neck squamous cell carcinoma: Consensus statements from an Italian expert panel 85
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial 82
Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: an international Delphi study 82
Treatment-related mortality in head and neck cancer patients receiving chemotherapy and radiation: results of a meta-analysis of published trials 82
A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy 80
Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology 79
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy 76
The 8th TNM classification for oral squamous cell carcinoma: What is gained, what is lost, and what is missing 74
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 73
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab 71
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study 71
Computer Vision Foundation Models in Endoscopy: Proof of Concept in Oropharyngeal Cancer 70
Role of Radiotherapy in the management of metastases from salivary gland carcinoma. 70
International, Multi-Institutional Evaluation of Practice Patterns and Outcomes for Recurrent and Metastatic Sinonasal Undifferentiated Carcinoma 69
M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy – A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 69
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin 69
USO DI MIRNA COME BIOMARCATORI PER LA DIAGNOSI E PROGNOSI DEL CARCINOMA ORALE A CELLULE SQUAMOSE 67
A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer 66
Phase IV study on the use of benzydamine mouthwash in radiation-induced oral mucositis in patients with head and neck cancer 66
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial 64
Italian version of the M.D. Anderson Symptom Inventory—Head and Neck Module: linguistic validation 64
ESMO Guidelines: Cancer patient management during the COVID-19 pandemic 64
International Expert-Based Consensus Definition, Classification Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Interdisciplinary Modified Delphi Study 63
Not all hematopoietic growth factors are created equal: Should we gain information for their use with immunotherapy? 62
Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma 62
Understanding Protective Mechanisms of an Oral Probiotic in Reducing Radiation-Induced Oral Mucositis 61
Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment 60
Is precision medicine the solution to improve organ preservation in laryngeal/hypopharyngeal cancer? A position paper by the Preserve Research Group 60
The Use of Artificial Intelligence in Head and Neck Cancers: A Multidisciplinary Survey 60
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian Centers 60
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines 60
A randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy of Aqualief™ mucoadhesive tablets in head and neck cancer patients who developed radiation-induced xerostomia 60
Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort 59
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life 58
A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy 58
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers 57
A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes 57
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma 57
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients 57
A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1] 56
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports 56
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma 56
The use of fentanyl in pain management in head and neck cancer patients: a narrative review 56
Editorial: Understanding and treating rare nasal and paranasal sinus cancers 55
A NATURAL HISTORY OF A SERIES OF RADIOACTIVE IODINE (131I-RAI)-RESISTANT ADVANCED DIFFERENTIATED THYROID CANCER (DTC) 55
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 55
Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines 55
Sinonasal Malignancies of Anterior Skull Base Histology-driven Treatment Strategies 54
Nutritional Support in Cancer patients: update of the Italian Intersociety Working Group practical recommendations 54
Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer? 54
Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area 54
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis 54
A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approaches 54
Health care-associated infections (HAIs) in head and neck carcinoma (HNC) patients treated with chemotherapy (CT) and/or radiotherapy (RT) 54
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients 53
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy 53
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 53
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma 53
Immune checkpoint inhibitor in high-risk oral potentially malignant disorders (IMPEDE study): An interim analysis on safety 53
Development of the MASCC/ISOO clinical practice guidelines for mucositis: an overview of the methods 53
Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC/ISOO framework 53
Nodal status in major salivary gland cancer: External validation of a novel N- classification 53
New insights in chemotherapy 53
Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: A systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 53
Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer 52
Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma 52
Expression of PDL-1 between primary and recurrent/metastatic head and neck squamous cell carcinoma: A bi-institutional retrospective concordance analysis (CONCORDL-1 study) 52
Peripherally or centrally inserted central catheters: what is the best vascular access device for cancer patients? 52
Role of TORS as De-Escalation Strategy in HPV-Related Oropharyngeal Cancer, What We Need to Know 51
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 51
FURTHER IMPROVEMENT IN OUTCOMES OF NASOPHARYNGEAL CARCINOMA WITH OPTIMIZED RADIOTHERAPY AND INDUCTION PLUS CONCOMITANT CHEMOTHERAPY: AN UPDATE OF THE MILAN EXPERIENCE 51
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 51
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma 51
Overview of oral potentially malignant disorders: From risk factors to specific therapies 51
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer 51
Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines 51
Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations 51
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer 51
Quality Assessment in Supportive Care in Head and Neck Cancer 51
RANK expression in EBV positive nasopharyngeal carcinoma metastasis: A ready-to-treat target? 50
Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment 50
Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy 50
The 2024 International Society of Oral Oncology-Multinational Association of Supportive Care in Cancer-American Society of Clinical Oncology guidelines for the prevention and management of osteoradionecrosis of the jaw 50
Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up 50
The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity 50
Diving into hot topics of salivary gland carcinoma management—an EORTC young and early career investigator survey 50
International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging System 50
Totale 6.582
Salva come PNG Salva come JPEG
Categoria #
all - tutte 118.911
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.911
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 2 0 0 0 1 0 0 1 0
2022/202334 4 0 2 4 5 3 0 1 11 2 1 1
2023/20241.254 2 2 6 0 0 0 1 434 43 53 251 462
2024/20254.244 138 26 56 86 45 395 214 189 825 1.141 533 596
2025/202613.643 1.797 902 705 992 466 739 3.790 616 681 988 799 1.168
2026/20271.574 818 756 0 0 0 0 0 0 0 0 0 0
Totale 20.763